1
|
Bordoni V, Casale M, Pinto VM, Carsetti R, Gianesin B, Gamberini MR, Mazdai L, Barella S, Denotti AR, Colavita F, Perrotta S, Maggio A, Pitrolo L, Quintino S, Caminati M, Mazzi F, Ceolan J, De Franceschi L, Forni GL, Locatelli F, Agrati C. Inflammatory and senescence-associated mediators affect the persistence of humoral response to COVID-19 mRNA vaccination in transfusion-dependent beta-thalassemic patients. Am J Hematol 2023; 98:E145-E147. [PMID: 36871203 DOI: 10.1002/ajh.26905] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2023] [Revised: 02/23/2023] [Accepted: 03/02/2023] [Indexed: 03/06/2023]
Affiliation(s)
- Veronica Bordoni
- Oncoematologia e Officina Farmaceutica, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - Maddalena Casale
- Dipartimento della Donna, del Bambino e di Chirurgia Generale e Specialistica, Università, degli Studi della Campania "Luigi Vanvitelli", Naples, Italy
| | - Valeria Maria Pinto
- Center for Microcythemia, Congenital Anemia, and Iron Dysmetabolism, Galliera Hospital, Genoa, Italy
| | - Rita Carsetti
- B-Cell Laboratory, Immunology Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - Barbara Gianesin
- Center for Microcythemia, Congenital Anemia, and Iron Dysmetabolism, Galliera Hospital, Genoa, Italy.,ForAnemia Foundation, Genoa, Italy
| | - Maria Rita Gamberini
- Day Hospital della Talassemia e delle Emoglobinopatie, Dipartimento di Medicina, Azienda Ospedaliero-Universitaria S. Anna, Cona, Italy
| | - Leila Mazdai
- Day Hospital della Talassemia e delle Emoglobinopatie, Dipartimento di Medicina, Azienda Ospedaliero-Universitaria S. Anna, Cona, Italy
| | - Susanna Barella
- SC Microcitemie e anemie rare, Ospedale Pediatrico Microcitemico "A. Cao", Cagliari, Italy
| | - Anna Rita Denotti
- SC Microcitemie e anemie rare, Ospedale Pediatrico Microcitemico "A. Cao", Cagliari, Italy
| | | | - Silverio Perrotta
- Dipartimento della Donna, del Bambino e di Chirurgia Generale e Specialistica, Università, degli Studi della Campania "Luigi Vanvitelli", Naples, Italy
| | - Aurelio Maggio
- Campus of Hematology Franco and Piera Cutino, AOOR Villa Sofia-V. Cervello, Palermo, Italy
| | - Lorella Pitrolo
- Campus of Hematology Franco and Piera Cutino, AOOR Villa Sofia-V. Cervello, Palermo, Italy
| | - Sabrina Quintino
- Center for Microcythemia, Congenital Anemia, and Iron Dysmetabolism, Galliera Hospital, Genoa, Italy
| | - Marco Caminati
- Department of Medicine, University of Verona & AOUI Verona, Verona, Italy
| | - Filippo Mazzi
- Department of Medicine, University of Verona & AOUI Verona, Verona, Italy
| | - Jacopo Ceolan
- Department of Medicine, University of Verona & AOUI Verona, Verona, Italy
| | | | - Gian Luca Forni
- Center for Microcythemia, Congenital Anemia, and Iron Dysmetabolism, Galliera Hospital, Genoa, Italy
| | - Franco Locatelli
- Oncoematologia e Officina Farmaceutica, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.,Catholic University of the Sacred Heart, Rome, Italy
| | - Chiara Agrati
- Oncoematologia e Officina Farmaceutica, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| |
Collapse
|
2
|
El-Battrawy I, Longo F, Núñez Gil IJ, Abumayyaleh M, Gianesin B, Estrada V, Aparisi Á, Arroyo-Espliguero R, Balocco M, Barella S, Beccaria A, Bonetti F, Casale M, De Michele E, Denotti AR, Fidone C, Fortini M, Gamberini MR, Graziadei G, Lisi R, Massa A, Marcon A, Rubinski B, Miano M, Motta I, Pinto VM, Piperno A, Mariani R, Putti MC, Quota A, Ribersani M, Marziali M, Roberti D, Rosso R, Tartaglione I, Vitucci A, Voi V, Zecca M, Romero R, Marouneld C, Fernández-Rozas I, Espejo C, Marhaeni W, Garcia Aguado M, Cappellini MD, Perrotta S, De Franceschi L, Piga A, Forni GL, Akin I. Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry. J Cell Mol Med 2022; 26:2520-2528. [PMID: 35355397 PMCID: PMC9077285 DOI: 10.1111/jcmm.17026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2021] [Revised: 09/18/2021] [Accepted: 09/30/2021] [Indexed: 11/29/2022] Open
Abstract
Although numerous patient-specific co-factors have been shown to be associated with worse outcomes in COVID-19, the prognostic value of thalassaemic syndromes in COVID-19 patients remains poorly understood. We studied the outcomes of 137 COVID-19 patients with a history of transfusion-dependent thalassaemia (TDT) and transfusion independent thalassaemia (TIT) extracted from a large international cohort and compared them with the outcomes from a matched cohort of COVID-19 patients with no history of thalassaemia. The mean age of thalassaemia patients included in our study was 41 ± 16 years (48.9% male). Almost 81% of these patients suffered from TDT requiring blood transfusions on a regular basis. 38.7% of patients were blood group O. Cardiac iron overload was documented in 6.8% of study patients, whereas liver iron overload was documented in 35% of study patients. 40% of thalassaemia patients had a history of splenectomy. 27.7% of study patients required hospitalization due to COVID-19 infection. Amongst the hospitalized patients, one patient died (0.7%) and one patient required intubation. Continuous positive airway pressure (CPAP) was required in almost 5% of study patients. After adjustment for age-, sex- and other known risk factors (cardiac disease, kidney disease and pulmonary disease), the rate of in-hospital complications (supplemental oxygen use, admission to an intensive care unit for CPAP therapy or intubation) and all-cause mortality was significantly lower in the thalassaemia group compared to the matched cohort with no history of thalassaemia. Amongst thalassaemia patients in general, the TIT group exhibited a higher rate of hospitalization compared to the TDT group (p = 0.001). In addition, the rate of complications such as acute kidney injury and need for supplemental oxygen was significantly higher in the TIT group compared to the TDT group. In the multivariable logistic regression analysis, age and history of heart or kidney disease were all found to be independent risk factors for increased in-hospital, all-cause mortality, whereas the presence of thalassaemia (either TDT or TIT) was found to be independently associated with reduced all-cause mortality. The presence of thalassaemia in COVID-19 patients was independently associated with lower in-hospital, all-cause mortality and few in-hospital complications in our study. The pathophysiology of this is unclear and needs to be studied in vitro and in animal models.
Collapse
Affiliation(s)
- Ibrahim El-Battrawy
- University of Mannheim, Mannheim, Germany.,Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
| | - Filomena Longo
- Hospital Clínico San Carlos, Universidad Complutense de Madrid, Instituto de Investigación, Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain
| | | | | | | | - Vicente Estrada
- Hospital Clínico San Carlos, Universidad Complutense de Madrid, Instituto de Investigación, Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain
| | | | | | - Manuela Balocco
- SSD Talassemia. Ospedale Pediatrico Microcitemico A. Cao, Cagliari, Italy
| | | | | | - Federico Bonetti
- Dipartimento della Donna, del Bambino e di Chirurgia Generale e Specialistica, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy
| | | | - Elisa De Michele
- Unità operativa semplice Studio Emoglobinopatie Simt, Ragusa, Italy
| | - Anna Rita Denotti
- SSD Talassemia. Ospedale Pediatrico Microcitemico A. Cao, Cagliari, Italy
| | - Carmelo Fidone
- Azienda Ospedaliero-Universitaria S.Anna di Ferrara, Ferrara, Italy
| | - Monica Fortini
- Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy
| | | | - Giovanna Graziadei
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.,Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Garibaldi, Catania, Italy
| | | | - Antonella Massa
- ASST-Monza, S.Gerardo Hospital, University of Milano-Bicocca, Monza, Italy
| | - Alessia Marcon
- Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.,Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | | | | | - Irene Motta
- Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.,Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | | | | | | | | | | | - Michela Ribersani
- Azienda Ospedaliero-Universitaria Policlinico "Vittorio Emanuele", Catania, Italy
| | - Marco Marziali
- Azienda Ospedaliera Universitaria Policlinico, Bari, Italy
| | - Domenico Roberti
- Dipartimento della Donna, del Bambino e di Chirurgia Generale e Specialistica, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy
| | | | - Immacolata Tartaglione
- Dipartimento della Donna, del Bambino e di Chirurgia Generale e Specialistica, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy
| | | | - Vincenzo Voi
- Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
| | - Marco Zecca
- Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
| | - Rodolfo Romero
- HOSPITAL UNIVERSITARIO LA PAZ, Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Madrid, Spain
| | | | | | - Carolina Espejo
- Pediatrics Department, Hematology-Oncology Division, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, Indonesia
| | - Wulandewi Marhaeni
- Cardiology Department, Hospital Puerta de Hierro de Majadahonda, Majadahonda, Madrid, Spain
| | - Marcos Garcia Aguado
- Department of Cardiology, BG Universitätsklinikum Bochum, Ruhr-Universität Bochum, Bochum, Germany
| | - Maria Domenica Cappellini
- Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.,Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Silverio Perrotta
- Dipartimento della Donna, del Bambino e di Chirurgia Generale e Specialistica, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy
| | | | - Antonio Piga
- Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
| | | | | |
Collapse
|
3
|
Longo F, Gianesin B, Voi V, Motta I, Pinto VM, Piolatto A, Spasiano A, Ruffo GB, Gamberini MR, Barella S, Mariani R, Fidone C, Rosso R, Casale M, Roberti D, Dal Zotto C, Vitucci A, Bonetti F, Pitrolo L, Quaresima M, Ribersani M, Quota A, Arcioni F, Campisi S, Massa A, De Michele E, Lisi R, Miano M, Bagnato S, Gentile M, Carrai V, Putti MC, Serra M, Gaglioti C, Migone De Amicis M, Graziadei G, De Giovanni A, Ricchi P, Balocco M, Quintino S, Borsellino Z, Fortini M, Denotti AR, Tartaglione I, Beccaria A, Marziali M, Maggio A, Perrotta S, Piperno A, Filosa A, Cappellini MD, De Franceschi L, Piga A, Forni GL. Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection. Am J Hematol 2022; 97:E75-E78. [PMID: 34861054 PMCID: PMC9011434 DOI: 10.1002/ajh.26429] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2021] [Revised: 11/23/2021] [Accepted: 11/29/2021] [Indexed: 12/04/2022]
Affiliation(s)
| | | | | | - Irene Motta
- Dipartimento di Scienze Cliniche e di Comunità Università degli Studi di Milano Milan Italy
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy
| | - Valeria Maria Pinto
- E.O. Ospedali Galliera Centro della Microcitemia e delle Anemie Congenite Genoa Italy
| | | | | | | | | | - Susanna Barella
- SSS Talassemia Ospedale Pediatrico Microcitemico A. Cao Cagliari Italy
| | - Raffaella Mariani
- University of Milano Bicocca, ASST‐Monza, S. Gerardo Hospital Monza Italy
| | | | | | - Maddalena Casale
- AOU Università degli Studi della Campania Luigi Vanvitelli Naples Italy
| | - Domenico Roberti
- AOU Università degli Studi della Campania Luigi Vanvitelli Naples Italy
| | | | | | | | | | | | | | | | | | | | | | | | - Roberto Lisi
- Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Garibaldi Catania Italy
| | | | | | | | | | | | | | | | | | | | - Anna De Giovanni
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy
| | | | - Manuela Balocco
- E.O. Ospedali Galliera Centro della Microcitemia e delle Anemie Congenite Genoa Italy
| | - Sabrina Quintino
- E.O. Ospedali Galliera Centro della Microcitemia e delle Anemie Congenite Genoa Italy
| | | | - Monica Fortini
- Azienda Ospedaliero‐Universitaria S.Anna di Ferrara Ferrara Italy
| | - Anna Rita Denotti
- SSS Talassemia Ospedale Pediatrico Microcitemico A. Cao Cagliari Italy
| | | | | | | | | | - Silverio Perrotta
- AOU Università degli Studi della Campania Luigi Vanvitelli Naples Italy
| | - Alberto Piperno
- University of Milano Bicocca, ASST‐Monza, S. Gerardo Hospital Monza Italy
| | | | | | | | - Antonio Piga
- Department of Clinical and Biological Sciences University of Torino Turin Italy
| | - Gian Luca Forni
- E.O. Ospedali Galliera Centro della Microcitemia e delle Anemie Congenite Genoa Italy
| |
Collapse
|